キメラ抗原受容体遺伝子改変T細胞(CAR-T)療法のレビュー【NEJM】

N Engl J Med 2018; 379: 64-73

Chimeric Antigen Receptor Therapy

From the Center for Cellular Immunotherapies, Perelman School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia (C.H.J.); and the Center for Cell Engineering, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York (M.S.).

 

 

 

コメント

Leave a comment

Your email address will not be published.


*